Towards 100 Year Legacy Our parent organization Terumo Corporation is racing towards its 100th year on September 17th 2021
Terumo Penpol personifies the story of a home grown R&D initiative commercialized successfully. Practicing the concept of “ Quality First ” approach in manufacturing, Terumo Penpol has been serving Blood Centers across the globe for more than 30 years.
About Terumo Penpol Private Limited
Terumo Penpol personifies the story of a home grown R&D initiative commercialized successfully. Practicing the concept of ” Quality First ” approach in manufacturing, Terumo Penpol has been serving Blood Centers across the globe for more than thirty years. Partnering with Terumo Corporation, Japan, a global leader in healthcare products, has enabled Terumo Penpol to harness the combined strengths in Technology and Manufacturing to continue redefining standards in Blood Transfusion.With Terumo’s acquisition of Caridian BCT, Terumo has become the world leader in Blood Management. The Blood Transfusion division of Terumo is being re-organized under the newly acquired company which has been renamed as Terumo BCT. The Apheresis and Cellular Therapy products of Terumo BCT complements Terumo Penpol products to provide a full range of blood collection, storage and processing solutions for Hospitals and Blood Centres in India and other countries.
Peninsula Polymers Private Limited originally incorporated in 1983, converted to Peninsula Polymers Limited in 1985 and to Terumo Penpol Limited in 1999 when TERUMO CORPORATION acquired majority shares. TERUMO PENPOL Limited now being the wholly owned subsidiary of Terumo Corporation, is converted to Terumo Penpol Private Limited.